Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Tessera Therapeutics at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Tessera Therapeutics brings 3 presentations to ASH 2026 in New Orleans. Its research centres on editing genes inside the body to treat blood disease. It covers correcting sickle cell disease in stem cells and making CAR-T cells in vivo using lipid nanoparticles.

OrganizationASH 2026 Attendance
Tessera Therapeutics
Somerville, MA
Biotech
Biotechnology company developing genetic medicines using gene writing.

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Tessera Therapeutics

Tell us what you sell and we’ll find the people at Tessera Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction